Correction to: Clinical Rheumatology
The original version of this article, unfortunately, contained errors and are now presented correctly in this article.
In the “Result” section under subtitle “ADAM-17 expression on inflammatory myopathy tissues” citation for “(Fig. 1a, b)” should have read as “(Fig. 1A, d)” and under the subtitle “Clinical characteristics of study subjects”, the line “CK and lactate dehydrogenase (LDH)” should have read as “KL-6”.
Figure 1 caption and the panel C image of the figure were also corrected as shown below:
ADAM-17 is expressed on the muscle tissue of an inflammatory myopathy patient. a–d Representative photomicrographs of muscle tissue samples from patients with inflammatory myopathy. a and c Cryosections were stained for ADAM-17. ADAM-17 expression on inflammatory cells (circle and arrow). a Original magnification, × 100. c Original magnification, × 400. b and d Cryosections were stained for control IgG. b Original magnification, × 100. d Original magnification, × 400
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at https://doi.org/10.1007/s10067-018-4014-5
Rights and permissions
About this article
Cite this article
Nishimi, A., Isozaki, T., Nishimi, S. et al. Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease. Clin Rheumatol 37, 1025–1026 (2018). https://doi.org/10.1007/s10067-018-4050-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-018-4050-1